Logo image of NB.CA

NIOCORP DEVELOPMENTS LTD (NB.CA) Stock Fundamental Analysis

TSX:NB - Toronto Stock Exchange - CA6544846091 - Common Stock - Currency: CAD

3.43  +0.37 (+12.09%)

Fundamental Rating

0

Overall NB gets a fundamental rating of 0 out of 10. We evaluated NB against 811 industry peers in the Metals & Mining industry. Both the profitability and financial health of NB have multiple concerns. NB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NB has reported negative net income.
NB had a negative operating cash flow in the past year.
In the past 5 years NB always reported negative net income.
NB had a negative operating cash flow in each of the past 5 years.
NB.CA Yearly Net Income VS EBIT VS OCF VS FCFNB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

NB has a Return On Assets of -204.62%. This is amonst the worse of the industry: NB underperforms 88.79% of its industry peers.
Industry RankSector Rank
ROA -204.62%
ROE N/A
ROIC N/A
ROA(3y)-86.35%
ROA(5y)-72.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NB.CA Yearly ROA, ROE, ROICNB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NB.CA Yearly Profit, Operating, Gross MarginsNB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, NB has more shares outstanding
Compared to 5 years ago, NB has more shares outstanding
Compared to 1 year ago, NB has a worse debt to assets ratio.
NB.CA Yearly Shares OutstandingNB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
NB.CA Yearly Total Debt VS Total AssetsNB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

NB has an Altman-Z score of -16.46. This is a bad value and indicates that NB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -16.46, NB is doing worse than 80.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -16.46
ROIC/WACCN/A
WACCN/A
NB.CA Yearly LT Debt VS Equity VS FCFNB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

NB has a Current Ratio of 0.16. This is a bad value and indicates that NB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.16, NB is doing worse than 86.60% of the companies in the same industry.
NB has a Quick Ratio of 0.16. This is a bad value and indicates that NB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.16, NB is not doing good in the industry: 85.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
NB.CA Yearly Current Assets VS Current LiabilitesNB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

NB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -166.67%.
EPS 1Y (TTM)-166.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.12% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y28.57%
EPS Next 2Y40.21%
EPS Next 3Y25.12%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NB.CA Yearly Revenue VS EstimatesNB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 200K 400K 600K
NB.CA Yearly EPS VS EstimatesNB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NB.CA Price Earnings VS Forward Price EarningsNB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NB.CA Per share dataNB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.5 -1 -1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as NB's earnings are expected to grow with 25.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.21%
EPS Next 3Y25.12%

More info and screens

0

5. Dividend

5.1 Amount

NB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NIOCORP DEVELOPMENTS LTD

TSX:NB (5/3/2024, 7:00:00 PM)

3.43

+0.37 (+12.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-12 2024-02-12/amc
Earnings (Next)05-28 2024-05-28/amc
Inst Owners0.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap119.76M
Analysts84.44
Price Target14.28 (316.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)3.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.86
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.72
OCFYN/A
SpS0
BVpS-0.27
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -204.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-86.35%
ROA(5y)-72.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z -16.46
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-166.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y28.57%
EPS Next 2Y40.21%
EPS Next 3Y25.12%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-349.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.37%
EBIT Next 3Y21.42%
EBIT Next 5YN/A
FCF growth 1Y-58.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-249.9%
OCF growth 3YN/A
OCF growth 5YN/A